drugset / Trial / NCT03573518
Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to assess safety and efficacy of various doses of BTX 1503 liquid formulation in subjects with moderate to severe acne vulgaris of the face.
Timeline
- Start
- 2018-06-26
- Primary completion
- 2019-08-16
- Completion
- 2019-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 2.5 % | — |
| Subject | Cannabidiol | Other / unclassified | 5 % | — |